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3) Analytical chemistry procedures Elemental Analysis
Elemental analysis was performed by Schwarzkopf Microanalytical Laboratory.
NMR Spectroscopy
All 1D 1 H-NMR experiments were carried out on Bruker Avance III 300 MHz or 400 MHz spectrometer at 298 K and analyzed with Topspin 3.0 software (Bruker). The 1D 13 C-NMR experiments were performed on Bruker DRX 300 MHz spectrometer at 298 K.
Infrared Spectroscopy (IR)
IR analysis of the solid compound sample was performed on Thermo Nicolet FTIR equipped with Zinc Selenide (ZnSe) Attenuated Total Reflectance (ATR) crystal accessory.
Liquid chromatography/Mass Spectrometry (LCMS)
LC/MS analysis was performed using Agilent 1100 series preparative HPLC (Agilent Technologies) coupled online to an Esquire 3000 Plus mass spectrometer (Bruker Daltonics), which consisted of nano-electrospray ionization source (ESI) and a quadrupole ion trap mass analyzer. 83, 170.24, 140.34, 121.58, 105.27, 89.67, 63.18, 58.96, 48.93, 42.46, 27.43, 26.07, 24.68 Intrinsic Tryptophan fluorescence assay. All fluorescence reading were carried out on a Tecan Infinity M200 microplate reader in a 384-well low volume, black bottom plates. Securinine was dissolved in 100% DMSO at 300 mM concentration and then diluted into Assay Buffer A (100 mM sodium phosphate buffer, pH 7, 2 mM EDTA) to make working stocks at 2X the needed concentrations (from 9000 µM to 70 µM). Each reaction well contained the indicated concentrations of securinine (from 4500 µM to 35 µM) or DMSO (1.5%) and 10 µM final concentration of PDIa in Assay Buffer A. The samples were incubated at 37 °C for 1 hr. and then emission spectra recorded from 300-to 400-nm wavelength with excitation at 295 nm. The maximum PDIa Trp fluorescence intensity was at 330 nm wavelength (λmax). Securinine did not shift the λmax. As a control emission spectra was S10 also recorded for compounds alone without PDIa (excitation of 295 nm). Securinine and PAO did not show any fluorescence between 300 and 400 nm on their own. All emission spectra are normalized by the maximum fluorescence intensity of PDIa only sample. Emission spectra were collected in triplicate and plotted as mean ± SEM and fitted to a log normal distribution equation in GraphPad Prism. ∆F was calculated by subtracting the Trp fluorescence intensity (at 330 nm wavelength) of the securinine treated samples from the Trp fluorescence intensity (at 330 nm) of the DMSO treated control. ∆Fmax is the maximum difference in Trp fluorescence between securinine and DMSO treated samples. ∆F/∆Fmax was calculated by diving ∆F of each securinine treated PDIa samples by the maximum ∆F (∆Fmax) of the series. The K d in Figure 5b was determined by fitting the data at each securinine concentration to the one-site total with non-specific binding equation in GraphPad Prism.
Compound
Reversibility Assay using Jump-Dilution Method. Securinine (10 mM), Phenylarsine oxide (3 mM), or DMSO only (3%), were incubated with 1 mM PDIa for 2 hr. at 37 °C in Assay Buffer A. After the incubation, the samples were diluted 1:100 with Assay Buffer A (now concentration is 10 µM PDIa with either 100 µM securinine, or 30 µM PAO, or 0.03% DMSO). 40 µl/well of the sample was added to the assay plate and emission spectra recorded from 300-to 400-nm wavelength with excitation at 295 nm. All emission spectra are normalized by the maximum fluorescence intensity of PDIa only sample. Emission spectra were collected in triplicate and plotted as mean ± SEM and fitted to a log normal distribution equation in GraphPad Prism.
Mouse microsome stability assay. Securinine (0.5 µM) was incubated at 37ºC for up to 45 minutes in 100 mM of potassium phosphate buffer pH 7.4 containing microsomal protein (0.5 mg/mL) and an NADPH generating system (0.34 mg/mL β-nicotinamide adenine dinucleotide phosphate (NADP), 1.56 mg/mL glucose-6-phosphate, 1.2 units/mL glucose-6-phosphate dehydrogenase). At 0, 5, 15, 30 and 45 min intervals an aliquot was taken and quenched with acetonitrile (ACN) containing internal standard. No-cofactor controls at 45 min were prepared.
Following completion of the experimentation, the samples were analyzed by LC-MS/MS. The half-life (t 1/2 ) is calculated using the following equation: t 1/2 = 0.693 / k Where, k is the elimination rate constant of test compounds obtained by fitting the data to the equation: C = initial × exp (-k × t). Intrinsic clearance (CL int ) is calculated as liver clearance from the half-life using the following equation: CL int = k × (ml incubation/ 0.5 mg protein) × (52.5 mg
